EP3788069 - T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 23.12.2022 Database last updated on 19.10.2024 | |
Former | Request for examination was made Status updated on 05.02.2021 | ||
Former | The international publication has been made Status updated on 08.11.2019 | ||
Former | unknown Status updated on 21.05.2019 | Most recent event Tooltip | 28.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325, MSC 7660 Bethesda, MD 20892-7660 / US | [2021/10] | Inventor(s) | 01 /
HANADA, Kenichi 5806 Greentree Road Bethesda, Maryland 20817 / US | 02 /
ZHAO, Chihao 9913 Montauk Avenue Bethesda, Maryland 20817 / US | 03 /
PASETTO, Anna Studentbacken 34, apt 1501 11557 Stockholm / SE | 04 /
YANG, James C. 5305 Roosevelt Street Bethesda, Maryland 20814 / US | [N/P] |
Former [2021/10] | 01 /
HANADA, Kenichi 5806 Greentree Road Bethesda, Maryland 20817 / US | ||
02 /
ZHAO, Chihao 9913 Montauk Avenue Bethesda, Maryland 20817 / US | |||
03 /
PASETTO, Anna Nybergsgatan 10, Apt 1303 11445 Stockholm / SE | |||
04 /
YANG, James C. 5305 Roosevelt Street Bethesda, Maryland 20814 / US | Representative(s) | Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [N/P] |
Former [2021/10] | Maiwald Patent- und Rechtsanwaltsgesellschaft mbH Elisenhof Elisenstraße 3 80335 München / DE | Application number, filing date | 19723615.1 | 01.05.2019 | [2021/10] | WO2019US30108 | Priority number, date | US201862665234P | 01.05.2018 Original published format: US 201862665234 P | [2021/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019213195 | Date: | 07.11.2019 | Language: | EN | [2019/45] | Type: | A1 Application with search report | No.: | EP3788069 | Date: | 10.03.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.11.2019 takes the place of the publication of the European patent application. | [2021/10] | Search report(s) | International search report - published on: | EP | 07.11.2019 | Classification | IPC: | C07K14/725 | [2021/10] | CPC: |
C07K14/7051 (EP,US);
A61K35/17 (US);
A61K39/4611 (EP);
A61K39/4632 (EP);
A61K39/464404 (EP);
G01N33/57492 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/10] | Title | German: | T-ZELLREZEPTOREN, DIE MUTIERTE EGFR ERKENNEN | [2021/10] | English: | T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR | [2021/10] | French: | RÉCEPTEURS DE LYMPHOCYTES T RECONNAISSANT UN EGFR MUTÉ | [2021/10] | Entry into regional phase | 22.11.2020 | National basic fee paid | 22.11.2020 | Designation fee(s) paid | 22.11.2020 | Examination fee paid | Examination procedure | 22.11.2020 | Examination requested [2021/10] | 22.11.2020 | Date on which the examining division has become responsible | 28.06.2021 | Amendment by applicant (claims and/or description) | 03.01.2023 | Despatch of a communication from the examining division (Time limit: M04) | 12.05.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 27.05.2021 | Renewal fee patent year 03 | 27.05.2022 | Renewal fee patent year 04 | 30.05.2023 | Renewal fee patent year 05 | 28.05.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2009126306 (CELL SIGNALING TECHNOLOGY INC [US], et al); | by applicant | US8034334 | US2012244133 | US8383099 |